IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone

Reproductive BioMedicine Online

Volumn 18, Issue 4, 2009, Pages 582-588

  Falconer, Henrik ^a   Sundqvist, J ^a   Gemzell Danielsson, K ^a   von Schoultz, B ^a   D'Hooghe, T M ^b   Freid, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

AMH; Cytokines; Endometriosis; FSH; Infertility; Ovarian reserve

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; FOLLITROPIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; RECOMBINANT FOLLITROPIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE REDUCTION; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE FLUID; OVULATION INDUCTION; PREGNANCY RATE; PROTEIN BLOOD LEVEL;

EID: 65249106016     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60138-1     Document Type: Article

References (42)

1. Agnholt J, Kelsen J, Brandsborg B et al. 2004 Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease - a possible target for infliximab treatment. European Journal of Gastroenterology and Hepatology 16, 649-655.
2. Akoum A, Lemay A, Paradis I et al. 1996 Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Human Reproduction 11, 2269-2275.
3. Al-Qahtani A, Groome NP 2006 Editorial: Anti-Mullerian hormone: Cinderella finds new admirers. Journal of Clinical Endocrinology and Metabolism 91, 3760-3762.
4. Andersen CY, Byskov AG 2006 Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. Journal of Clinical Endocrinology and Metabolism 91, 4064-4069.
5. Arici A, Matalliotakis I, Goumenou A et al. 2003 Increased levels of interleukin- 15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Human Reproduction 18, 429-432.
6. Barnhart K, Dunsmoor-Su R, Coutifaris C 2002 Effect of endometriosis on in vitro fertilization. Fertility and Sterility 77, 1148-1155.
7. Bath LE, Wallace WH, Shaw MP et al. 2003 Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Human Reproduction 18, 2368-2374.
8. Brannstrom M, Friden BE, Jasper M et al. 1999 Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum. European Journal of Obstetrics & Gynecology and Reproductive Biology 83, 213-217.
9. Bullimore DW 2003 Endometriosis is sustained by tumour necrosis factor-alpha. Medical Hypotheses 60, 84-88.
10. Carlberg M, Nejaty J, Froysa B, et al. 2000 Elevated expression of tumour necrosis factor alpha in cultured granulosa cells from women with endometriosis. Human Reproduction 15, 1250-1255.
11. D'Hooghe TM, Debrock S, Hill JA et al. 2003 Endometriosis and subfertility: is the relationship resolved? Seminars in Reproductive Medicine 21, 243-254.
12. D'Hooghe TM, Nugent NP, Cuneo S et al. 2006 Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Biology of Reproduction 74, 131-136.
13. Di Sabatino A, Ciccocioppo, R, Cinque B et al. 2004 Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut 53, 70-77.
14. Driancourt MA, Thuel B 1998 Control of oocyte growth and maturation by follicular cells and molecules present in follicular fluid. A review. Reproduction Nutrition Development 38, 345-362.
15. Durlinger AL, Gruijters MJ, Kramer P et al. 2001 Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142, 4891-4899.
16. Eldar-Geva T, Margalioth EJ, Gal M et al. 2005 Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Human Reproduction 20, 1814-1819.
17. Falconer H, Mwenda JM, Chai DC et al. 2006 Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Human Reproduction 21, 1856-1862.
18. Fanchin R, Schonauer LM, Righini C et al. 2003 Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Human Reproduction 18, 328-332.
19. Fanchin R, Mendez Lozano DH, Frydman N et al. 2007 Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. Journal of Clinical Endocrinology and Metabolism 92, 1796-1802.
20. Fried G, Harlin J, Csemiczky G et al. 1996 Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG. Human Reproduction 11, 474-477.
21. Gromoll J, Simoni M, Nordhoff V et al. 1996 Functional and clinical consequences of mutations in the FSH receptor. Molecular and Cellular Endocrinology 125, 177-182.
22. Halis G, Arici A 2004 Endometriosis and inflammation in infertility. Annals of the New York Academy of Sciences 1034, 300-315.
23. Hong CY, Park JH, Seo KH et al. 2003 Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B. Molecular and Cellular Biology 23, 6000-6012.
24. Jacobsen TZ, Barlow DH, Koninckx PR et al. 2002 Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Systematic Reviews CD001398
25. Kageyama Y, Takahashi M, Torikai E et al. 2007 Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis. Clinical Rheumatology 26, 505-509.
26. Kennedy S, Bergqvist A, Chapron C et al. 2005 ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction 20, 2698-2704.
27. Kilic S, Evsen M, Tasdemir N et al. 2007 Follicular fluid vascular endothelial growth factor and tumour necrosis factor alpha concentrations in patients with endometriosis undergoing ICSI. Reproductive BioMedicine Online 15, 316-320.
28. Kuroda T, Lee MM, Haqq CM et al. 1990 Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology 127, 1825-1832.
29. Lee KS, Joo BS, Na YJ et al. 2000 Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. Journal of Assisted Reproduction and Genetics 17, 222-228.
30. Lemos NA, Arbo E, Scalco R et al. 2008 Decreased anti-Mullerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis. Fertility and Sterility 89, 1064-1068.
31. Loukides JA, Loy RA, Edwards R et al. 1990 Human follicular fluids contain tissue macrophages. Journal of Clinical Endocrinology and Metabolism 71, 1363-1367.
32. Naz RK, Zhu X, Menge AC 1997 Expression of tumor necrosis factor-alpha and its receptors type I and type II in human oocytes. Molecular and Reproductive Development 47, 127-133.
33. Nelson SM, Yates RW, Fleming R 2007 Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy. Human Reproduction 22, 2414-2421.
34. Pizzo A, Salmeri FM, Ardita FV et al. 2002 Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecologic and Obstetric Investigation 54, 82-87.
35. Punnonen J, Heinonen PK, Teisala K et al. 1992 Demonstration of tumor necrosis factor-alpha in preovulatory follicular fluid: its association with serum 17 beta-estradiol and progesterone. Gynecologic and Obstetric Investigation 33, 80-84.
36. Rice VM, Williams VR, Limback SD et al. 1996 Tumour necrosis factor-alpha inhibits follicle-stimulating hormone-induced granulosa cell oestradiol secretion in the human: dependence on size of follicle. Human Reproduction 11, 1256-1261.
37. Shen C, Maerten P, Geboes K et al. 2005 Infliximab, induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clinical Immunology 115, 250-259.
38. Tanbo T, Dale PO, Lunde O et al. 1992 Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clorniphene citrate-stimulated follicle-stimulating hormone levels. Fertility and Sterility 57, 819-824.
39. van Rooij IA, Broekmans FJ, Scheffer GJ et al. 2005 Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertility and Sterility 83, 979-987.
40. Visser JA, de Jong FH, Laven JS et al. 2006 Anti-Multerian hormone: a new marker for ovarian function. Reproduction 131, 1-9.
41. Wieser F, Fabjani G, Tempfer C et al. 2002 Tumor necrosis factor-alpha promotor polymorphisms and endometriosis. Journal of the Society for Gynecologic Investigation 9, 313-318.
42. Wunder DM, Guibourdenche J, Birkhauser MH et al. 2008 Anti-Mullerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility 90, 2203-2210.